Author Interviews, JAMA, Osteoporosis / 26.11.2019
Effect of Anticoagulants Warfarin vs DOACs on Bone Health
MedicalResearch.com Interview with:
Pamela L. Lutsey, PhD
Associate Professor
Division of Epidemiology and Community Health
University of Minnesota School of Public Health
Minneapolis
MedicalResearch.com: What is the background for this study?
Response: Warfarin is prescribed to atrial fibrillation (AF) patients for the prevention of cardioembolic complications. However, whether it adversely impacts bone health is controversial.
With the availability of alternate direct oral anticoagulant (DOAC) options, it is now possible to evaluate the comparative safety of warfarin in relation to fracture risk.
(more…)